[1]
Muni, M. et al. 2025. Feasibility Study for the Development of Combination Dosage Form Containing Aspirin and Omeprazole for Treating Cardiovascular and Cerebrovascular Events. Bangladesh Pharmaceutical Journal. 28, 1 (Jan. 2025), 105–113. DOI:https://doi.org/10.3329/bpj.v28i1.79470.